Insider Transactions in Q4 2024 at Travere Therapeutics, Inc. (TVTX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 26
2024
|
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-21.45%
|
$255,000
$17.22 P/Share
|
|
Dec 26
2024
|
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+17.66%
|
$180,000
$12.67 P/Share
|
|
Nov 25
2024
|
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
12,090
-18.04%
|
$217,620
$18.3 P/Share
|
|
Nov 25
2024
|
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+18.29%
|
$180,000
$12.67 P/Share
|
|
Oct 04
2024
|
Gary A Lyons |
SELL
Open market or private sale
|
Direct |
40,000
-25.11%
|
$560,000
$14.75 P/Share
|
|
Oct 04
2024
|
Gary A Lyons |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+30.53%
|
$400,000
$10.48 P/Share
|